Testing for the presence of cancer requires the outmost personal care and consideration. In the process of cancer diagnosis, molecular characterization by somatic mutation testing is enormously beneficial for improving the prognosis and the quality of life of cancer-affected patients.
Genetic information has the power to transform clinical decisions, guide therapy selection, and allow disease risk profiling.
Bioscience Institute is dedicated to utilizing genomics in order to advance precision medicine for cancer. Using Next-Generation Sequencing (NGS)-based assays, we offer a variety of options, including targeted panels that analyze genes directly linked to specific cancers through scientific research.
Our HeliDx genetic tests are performed at our accredited, high quality labs, that regularly take part in external quality assurance schemes. The cancer panels used are designed to identify all four classes of actionable genomic alterations, including base substitutions, insertions and deletions, copy number alterations and selected fusions. Both tissue samples and liquid biopsy samples are supported.
